Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $227,021 | 133 | 59.0% |
| Travel and Lodging | $80,526 | 169 | 20.9% |
| Honoraria | $42,334 | 18 | 11.0% |
| Consulting Fee | $18,833 | 9 | 4.9% |
| Food and Beverage | $15,783 | 507 | 4.1% |
| Education | $61.71 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corcept Therapeutics | $325,269 | 454 | $0 (2024) |
| RECORDATI_RARE_DISEASES_INC. | $42,108 | 36 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $11,597 | 56 | $0 (2024) |
| ABBVIE INC. | $1,580 | 91 | $0 (2024) |
| Novo Nordisk Inc | $582.94 | 38 | $0 (2024) |
| Lilly USA, LLC | $518.16 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $514.03 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $220.86 | 12 | $0 (2023) |
| IBSA Pharma Inc. | $216.44 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $214.47 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126,193 | 270 | Corcept Therapeutics ($107,362) |
| 2023 | $94,878 | 237 | Corcept Therapeutics ($91,801) |
| 2022 | $66,039 | 176 | Corcept Therapeutics ($59,750) |
| 2021 | $97,448 | 156 | Corcept Therapeutics ($66,355) |
All Payment Transactions
839 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/19/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Honoraria | Cash or cash equivalent | $1,050.00 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/19/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Honoraria | Cash or cash equivalent | $1,050.00 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/19/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Honoraria | Cash or cash equivalent | $525.00 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $340.00 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | ABBVIE INC. | SYNTHROID (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Honoraria | Cash or cash equivalent | $1,050.00 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/02/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Travel and Lodging | Cash or cash equivalent | $27.47 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | Cash or cash equivalent | $37.16 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | Cash or cash equivalent | $33.82 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | Cash or cash equivalent | $28.72 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $25.59 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | Cash or cash equivalent | $8.15 | General |
| Category: Endocrinology | ||||||
| 11/15/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/14/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Honoraria | Cash or cash equivalent | $2,100.00 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/14/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $75.60 | General |
| Category: ENDOCRINE AGENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 130 | 232 | $55,425 | $27,432 |
| 2022 | 3 | 105 | 170 | $41,425 | $21,136 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 181 | $40,725 | $21,778 | 53.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $5,950 | $2,403 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $4,200 | $1,701 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $4,550 | $1,551 | 34.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 129 | $29,025 | $16,076 | 55.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $9,800 | $3,908 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 13 | $2,600 | $1,152 | 44.3% |
About Alison Gracom, PA
Alison Gracom, PA is a Medical healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245496843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alison Gracom, PA has received a total of $384,559 in payments from pharmaceutical and medical device companies, with $126,193 received in 2024. These payments were reported across 839 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($227,021).
As a Medicare-enrolled provider, Gracom has provided services to 235 Medicare beneficiaries, totaling 402 services with total Medicare billing of $48,568. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Medical
- Location Irvine, CA
- Active Since 08/03/2008
- Last Updated 02/07/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1245496843
Products in Payments
- Korlym (Drug) $325,269
- RECORLEV (Drug) $10,874
- ISTURISA (Drug) $10,221
- VRAYLAR (Drug) $796.79
- JARDIANCE (Drug) $611.33
- GVOKE HYPOPEN (Drug) $525.00
- UBRELVY (Drug) $391.67
- SIGNIFOR LAR (Drug) $239.55
- SYNTHROID (Drug) $215.99
- Ozempic (Drug) $202.94
- GVOKE PFS (Drug) $197.91
- FARXIGA (Drug) $193.76
- BELSOMRA (Drug) $178.35
- Wegovy (Drug) $162.11
- QULIPTA (Drug) $141.09
- Tymlos (Drug) $136.58
- TRULICITY (Drug) $127.75
- QUVIVIQ (Drug) $127.46
- EMGALITY (Drug) $126.78
- Licart (Drug) $125.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Irvine
Kristine Nguyen, Pa-C, PA-C
Medical — Payments: $22,996
Mrs. Stacy Vencill, Pa-C, PA-C
Medical — Payments: $14,072
Samantha Cohen, Pa, PA
Medical — Payments: $2,206
Jenny Luong, Rpa-C, RPA-C
Medical — Payments: $1,914
Karli Koval, Pa-C, PA-C
Medical — Payments: $422.94
Mrs. Amy Newman, Pa-C, PA-C
Medical — Payments: $197.06